156 related articles for article (PubMed ID: 11025904)
1. Ventricular pacing failure after a single oral dose of pilsicainide in a patient with a permanent pacemaker and paroxysmal atrial fibrillation.
Numata T; Abe H; Nagatomo T; Kohshi K; Nakashima Y
Pacing Clin Electrophysiol; 2000 Sep; 23(9):1436-8. PubMed ID: 11025904
[TBL] [Abstract][Full Text] [Related]
2. Effect of a single oral dose of pilsicainide on pacing thresholds in pacemaker patients with and without paroxysmal atrial fibrillation.
Numata T; Abe H; Nagatomo T; Kohshi K; Nakashima Y
Jpn Circ J; 2000 Oct; 64(10):750-4. PubMed ID: 11059614
[TBL] [Abstract][Full Text] [Related]
3. Conversion of recent-onset Atrial Fibrillation by a single oral dose of Pilsicainide (Pilsicainide Suppression Trial on atrial fibrillation). The PSTAF Investigators.
Atarashi H; Inoue H; Hiejima K; Hayakawa H
Am J Cardiol; 1996 Sep; 78(6):694-7. PubMed ID: 8831412
[TBL] [Abstract][Full Text] [Related]
4. A case of sinus pause due to the proarrhythmia of pilsicainide.
Toeda T; Susa R; Saigawa T; Abe T; Yamaguchi Y; Fuse K; Murooka H
Jpn Heart J; 2000 May; 41(3):405-10. PubMed ID: 10987357
[TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy of hybrid pharmacologic and ablation therapy in patients with pilsicainide-induced atrial flutter.
Hirao K; Okishige K; Yamamoto N; Otomo K; Azegami K; Isobe M
Clin Cardiol; 2005 Jul; 28(7):338-42. PubMed ID: 16075827
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological conversion of persistent atrial fibrillation into sinus rhythm with oral pilsicainide: pilsicainide suppression trial for persistent atrial fibrillation II.
Okishige K; Fukunami M; Kumagai K; Atarashi H; Inoue H;
Circ J; 2006 Jun; 70(6):657-61. PubMed ID: 16723783
[TBL] [Abstract][Full Text] [Related]
7. Pilsicainide for conversion and maintenance of sinus rhythm in chronic atrial fibrillation: a placebo-controlled, multicenter study.
Okishige K; Nishizaki M; Azegami K; Igawa M; Yamawaki N; Aonuma K;
Am Heart J; 2000 Sep; 140(3):e13. PubMed ID: 10966544
[TBL] [Abstract][Full Text] [Related]
8. Pilsicainide.
Plosker GL
Drugs; 2010 Mar; 70(4):455-67. PubMed ID: 20205487
[TBL] [Abstract][Full Text] [Related]
9. Single oral administration of pilsicainide versus infusion of disopyramide for termination of paroxysmal atrial fibrillation: a multicenter trial.
Kumagai K; Abe H; Hiraki T; Nakashima H; Oginosawa Y; Ikeda H; Nakashima Y; Imaizumi T; Saku K
Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):1880-2. PubMed ID: 11139948
[TBL] [Abstract][Full Text] [Related]
10. Low-dose flecainide infusion followed by oral pilsicainide is highly effective and safe for paroxysmal atrial fibrillation.
Nagai S; Takeishi Y; Kubota I
Cardiovasc Drugs Ther; 2003 Jan; 17(1):95-7. PubMed ID: 12916520
[TBL] [Abstract][Full Text] [Related]
11. [Brugada syndrome associated with ventricular fibrillation induced by administration of pilsicainide: a case report].
Matsumoto K; Sumita S; Ishikawa T; Matsushita K; Kobayashi T; Ohkusu Y; Yamakawa Y; Nakagawa T; Nakazawa I; Mochida Y; Ebina T; Uchino K; Kimura K; Umemura S
J Cardiol; 2003 Nov; 42(5):227-34. PubMed ID: 14658412
[TBL] [Abstract][Full Text] [Related]
12. Bifocal versus unifocal right atrial pacing under plasma level controlled sotalol to prevent atrial fibrillation in patients with symptomatic sinus bradycardia and paroxysmal atrial fibrillation.
Stockburger M; Gerhardt L; Helms S; Schlegl M; Butter C
Herzschrittmacherther Elektrophysiol; 2007 Dec; 18(4):250-8. PubMed ID: 18084799
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of antiarrhythmic effects of class Ic drugs in paroxysmal atrial fibrillation in man.
Matsuo K; Kumagai K; Annoura M; Ideishi M; Arakawa K
Cardiology; 1998; 89(2):119-23. PubMed ID: 9524012
[TBL] [Abstract][Full Text] [Related]
14. A case of sick sinus syndrome that developed torsades de pointes, pacing failure and sensing failure during administration of bepridil.
Ohsawa M; Tanaka F; Kunugita F; Saito H; Nakamura M; Shiroto T; Hotta K; Chiba N; Hiramori K
Jpn Heart J; 2003 Sep; 44(5):783-8. PubMed ID: 14587660
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of pilsicainide hydrochloride for injection in healthy Chinese volunteers: a randomized, parallel-group, open-label, single-dose study.
Qiu Q; Liu W; Li J; Wei Y; Yang K; Suo W; Wu W; Du H; Zhang Y; Zhao G; Zhou Z; Zheng Y; Lin Y
Clin Ther; 2014 Feb; 36(2):255-63. PubMed ID: 24480637
[TBL] [Abstract][Full Text] [Related]
16. A case of the toxicity of pilsicainide hydrochloride with comparison of the serial serum pilsicainide levels and electrocardiographic findings.
Horita Y; Kanaya H; Uno Y; Yamazaki T; Kaku B; Funada A; Kitajima S; Matsumura M; Satoh T
Jpn Heart J; 2004 Nov; 45(6):1049-56. PubMed ID: 15655281
[TBL] [Abstract][Full Text] [Related]
17. [Factors for successful conversion of atrial fibrillation using intravenous injection of pilsicainide hydrochloride].
Matsushita K; Ishikawa T; Sumita S; Kobayashi T; Matsumoto K; Yamakawa Y; Ohkusu Y; Nakagawa T; Nakazawa I; Mochida Y; Ebina T; Uchino K; Kimura K; Umemura S
J Cardiol; 2003 Aug; 42(2):81-6. PubMed ID: 12964518
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiologic and hemodynamic effects of a single oral dose of pilsicainide hydrochloride, a new class 1c antiarrhythmic agent.
Ino T; Atarashi H; Kuruma A; Onodera T; Saitoh H; Hayakawa H
J Cardiovasc Pharmacol; 1998 Jan; 31(1):157-64. PubMed ID: 9456290
[TBL] [Abstract][Full Text] [Related]
19. Pilsicainide for atrial fibrillation.
Kumagai K; Nakashima H; Tojo H; Yasuda T; Noguchi H; Matsumoto N; Ogawa M; Saku K
Drugs; 2006; 66(16):2067-73. PubMed ID: 17112301
[TBL] [Abstract][Full Text] [Related]
20. Physiologic atrial cardiac pacing for the prevention of chronic atrial fibrillation associated with sick sinus syndrome.
Otaki M; Inoue T; Kaneda T; Oku H
ASAIO J; 2002; 48(1):110-2. PubMed ID: 11814087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
